Heart Failure

June 08, 2020

When it comes to COVID-19, the science is changing rapidly.  Every specialty is struggling to keep pace with the massive amounts of new information coming out virtually every day.  And cardiology is no exception. Today I’m speaking with Dr. Yishay Szekely , a cardiologist from Tel aviv University about what his team has learned about how COVID-19 affects the heart from echocardiography.  Their paper was published last week in the American Heart Association journal Circulation, and what he says is that sometimes you have one idea about what’s happening – but once you are able to visualize it – the results can surprise you.

May 27, 2020

New research published today in the Journal of the American Heart Association, concluded that palliative measures can significantly lower the risk of repeated hospital admissions and the need for invasive procedures such as mechanical ventilation and defibrillator implantation.

May 25, 2020

New research published in JACC: Heart Failure shows that in patients with heart failure, low health literacy increases the rates of hospitalization and mortality.

May 18, 2020

Researchers from UVA Health have recently published a paper with the intent on educating emergency room physicians about the cardiac complications of COVID-19.

May 07, 2019

A secondary analysis of results from the VISTA-16 trial suggests that serial hsCRP measurements may improve post-ACS risk stratification and help decrease subsequent CV events.  

April 29, 2019

Close to 70% of hearts consented for donation in the US are never transplanted. A portable perfusion technology now under FDA review could significantly reduce that.

April 22, 2019

In patients hospitalized for heart failure, influenza was found to be an independent predictor of complications, extended stay, and death while in hospital.

April 09, 2019

Heart pumps may work just as well as heart transplants for older heart failure patients and complex cases, finds a study presented at the ISHLT annual meeting.

February 19, 2019

Statins decrease major vascular events like stroke and heart attack regardless of age. While the evidence is less robust for people over age 75, evidence suggest this age group may also benefit, a new study shows.

February 19, 2019

Adding a neprilysin inhibitor to an angiotensin receptor blocker may benefit patients hospitalized for acute heart failure more than an angiotensin receptor blocker alone, a study shows.